Value of the histopathological features in predicting B-RAF status in cutaneous malignant melanoma

被引：0
|
作者：
Penaranda, J. M. Suarez [1 ]
Silva, O. Figueroa [1 ]
Gestal, A. Estany [1 ]
Bouso, M. [1 ]
Aliste, C. [1 ]
Aguilar, M. D. Sanchez [1 ]
机构：
[1] Clin Hosp, Dept Pathol, Santiago De Compostela, Spain
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-15-012
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [21] B-Raf: How One Mutation Leads to Melanoma
    Zhao, Hongru
    Choe, Jana
    Leng, Yunzhao
    Alex, Katherine
    FASEB JOURNAL, 2022, 36
  • [22] Differential prognostic impact of the mutational status of B-RAF and N-RAS in melanoma
    Ugurel, S
    Thirumaran, RK
    Blöthner, S
    Gast, A
    Sucker, A
    Müller-Berhaus, J
    Rittgen, W
    Hemminki, K
    Kumar, R
    Schadendorf, D
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) : 234 - 234
  • [23] Management of metastatic melanoma: B-raf kinase inhibitors
    McCormack, C.
    McArthur, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2010, 51 : A3 - A3
  • [24] B-RAF as a melanoma susceptibility candidate gene.
    Bressac-de Paillerets, B
    Laud, K
    Avril, MF
    Chompret, A
    Lenoir, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 233 - 233
  • [25] B-Raf specific antibody responses in melanoma patients
    Joachim Fensterle
    Jürgen C Becker
    Tamara Potapenko
    Veronika Heimbach
    Claudia S Vetter
    Eva B Bröcker
    Ulf R Rapp
    BMC Cancer, 4
  • [26] B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells
    Roos, Wynand P.
    Quiros, Steve
    Krumm, Andrea
    Merz, Stephanie
    Switzeny, Olivier Jerome
    Christmann, Markus
    Loquai, Carmen
    Kaina, Bernd
    ONCOTARGET, 2014, 5 (24) : 12607 - 12620
  • [27] Differential roles of Raf-1 and B-Raf in uveal melanoma tumorigenesis
    Mascarelli, F
    Calipel, A
    Glotin, AL
    Cohen-Behar, F
    Mouriaux, F
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [28] The clinical and histopathological characteristics of cutaneous malignant melanoma
    Coel, Cavit
    Tunc, Guenduez
    Yandakci, Kemal
    Hasdemir, Oguz
    Yalcin, Erol
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2007, 24 (03): : 228 - 234
  • [29] A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma
    Babu, Arunkumar
    Laila, Shiny P.
    Fernandez, Annette
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (15) : 2066 - 2074
  • [30] RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells
    Fan, Fengjuan
    Feng, Lin
    He, Jing
    Wang, Xiao
    Jiang, Xiaomeng
    Zhang, Yixuan
    Wang, Zhenzhen
    Chen, Yan
    CARCINOGENESIS, 2008, 29 (06) : 1157 - 1163
12345